Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/68857
Title: Efficacy Of 100 Mg SC Mepolizumab For Severe Eosinophilic Asthma (SEA) Across Blood Eosinophil Counts: Meta-Analysis
Authors: 
Filiation: 
[Yancey, Steven W.] GSK, Resp Therapeut Area, Res Triangle Pk, NC USA
[Bradford, Eric S.] GSK, Resp Therapeut Area, Res Triangle Pk, NC USA
[Albers, Frank] GSK, Resp Med Franchise, Durham, NC USA
[Bratton, Daniel J.] GSK, Clin Stat, Stockley Pk, England
[Kwon, Namhee] GSK, Resp Med Franchise, London, England
[Chanez, Pascal] Aix Marseille Univ, Dept Resp Med, Marseille, France
[Chanez, Pascal] Aix Marseille Univ, CIC Nord, Marseille, France
[Licskai, Christopher] Western Univ, Schulich Sch Med & Dent, London, ON, Canada
[Quirce, Santiago] Hosp La Paz Inst Hlth Res IdiPAZ, Dept Allergy, Madrid, Spain
Name of conference: Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)
Issue Date: 1-Feb-2019
Publisher: Mosby-elsevier
URI: https://hdl.handle.net/20.500.12530/68857
ISSN: 0091-6749
Appears in Collections:Hospitales > H. U. La Paz > Comunicaciones a congresos

Files in This Item:
The file with the full text of this item is not available due to copyright restrictions or because there is no digital version. Authors can contact the head of the repository of their center to incorporate the corresponding file.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.